General Information
Forest Hypertension NAC-MD-01
A Multicenter, Randomized, Double-blind, Placebo-Controlled, 8-Week Study to Evaluate the Safety and Efficacy of Nebivolol and Valsartan Given as a Fixed-Dose Combination in Patients With Stage 1 or 2 Essential Hypertension.
| Protocol | |
|---|---|
| Identifier | NAC-MD-01 |
| UID | 03bebabe-129b-441a-b175-9ebdb46f9712 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Hypertension / Adult |
| Launch Year | 2012 |
| NCT Number | - |
| Created | 2012-07-24 15:48 |
| Last Updated | 2012-07-24 15:48 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2012-11-21 | No |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2012-10-15 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2013-05-28 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Pereira, Cynthia | CPereira | No |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Forest Research Institute |
|---|---|
| Division | Forest Research Institute |
| Team | Forest Research Institute |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | 26579/450 |
|---|---|
| CRO | |
| CRO Ref | CRA: Karen Le Tel 949-861-8301 |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
